# Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy

> **NCT04939883** · PHASE4 · UNKNOWN · sponsor: **Hospital Sirio-Libanes** · enrollment: 1018 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Carvedilol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04939883
- **Lead sponsor:** Hospital Sirio-Libanes
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 1018 (ESTIMATED)
- **Last updated:** 2024-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04939883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04939883, "Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04939883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*